Advances in Biomarker Sciences and Technology
KeAi Communications Co. Ltd.
About the journal
Advances in Biomarker Sciences and Technology is an open-access journal published by KeAi Communications Co. Ltd. in China, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 700 USD. Declared review time at DOAJ: 20 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- KeAi Communications Co. Ltd.
- ISSN
- 2543-1064
- Country
- China
- Languages
- english
- Access
- Open access
- Declared publication charge
- 700 USD
- Articles in DOAJ
- 86
- Declared review time
- 20 weeks
- Declared peer-review model
- peer_review
Index listings
- DOAJ · 2021-03-31
- Indexing
- DOAJ
- APC
- 700 USD
- Declared review time (DOAJ)
- 20 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
86
Most recent article
4 months ago
Average review time (journal-declared via DOAJ)
20weeks
Works in OpenAlex
128
Last recorded publication year
2026
h-index
12
i10-index
14
From OpenAlex open data (CC0).
Editorial & policy11
- Last DOAJ review date
- 2024-04-04
- Added to DOAJ
- 2021-03-31
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 95%
- ORCID iDs in current deposits
- 74%
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101774593
Classification6
Subjects (DOAJ)
LCC codes
Subject areas
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Essential Oils and Antimicrobial Activity
- Gut microbiota and health
- Essential Oils and Antimicrobial Activity
- Gut microbiota and health
- Cancer-related molecular mechanisms research
Show all subjects (50)
- COVID-19 Clinical Research Studies
- COVID-19 Clinical Research Studies
- Artificial Intelligence in Healthcare
- Metabolomics and Mass Spectrometry Studies
- Computational Drug Discovery Methods
- Liver Disease Diagnosis and Treatment
- Brain Tumor Detection and Classification
- Artificial Intelligence in Healthcare
- Liver Disease Diagnosis and Treatment
- Computational Drug Discovery Methods
- Brain Tumor Detection and Classification
- Metabolomics and Mass Spectrometry Studies
- Nanoplatforms for cancer theranostics
- Medicinal Plants and Neuroprotection
- Glioma Diagnosis and Treatment
- SARS-CoV-2 and COVID-19 Research
- Phytochemicals and Medicinal Plants
- Chronic Kidney Disease and Diabetes
- Adipokines, Inflammation, and Metabolic Diseases
- Natural Antidiabetic Agents Studies
- Parasitic Diseases Research and Treatment
- SARS-CoV-2 detection and testing
- Circular RNAs in diseases
- Ethnobotanical and Medicinal Plants Studies
- Cancer, Hypoxia, and Metabolism
- Cancer Research and Treatments
- S100 Proteins and Annexins
- Circular RNAs in diseases
- Biosensors and Analytical Detection
- Nanoplatforms for cancer theranostics
- SARS-CoV-2 and COVID-19 Research
- Glioma Diagnosis and Treatment
- Chronic Kidney Disease and Diabetes
- Adipokines, Inflammation, and Metabolic Diseases
- Natural Antidiabetic Agents Studies
- SARS-CoV-2 detection and testing
- Phytochemicals and Medicinal Plants
- Medicinal Plants and Neuroprotection
- Ethnobotanical and Medicinal Plants Studies
- Cancer, Hypoxia, and Metabolism
- S100 Proteins and Annexins
- Biosensors and Analytical Detection
Keywords (DOAJ)
- molecular epidemiology
- toxicology
- biomarkers and technology
- clinic diagonsis and treatment
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ